US Stock MarketDetailed Quotes

MEIP MEI Pharma

Watchlist

2.8400
+0.0400+1.43%

Trading Nov 21 15:33 ET

18.92MMarket Cap-406P/E (TTM)

MEI Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

38.08%-11.45M

3.83%-50.47M

-59.25%-18M

75.86%-2.93M

22.53%-11.06M

-25.09%-18.49M

-7.67%-52.48M

27.10%-11.3M

28.46%-12.13M

-66.59%-14.27M

Net income from continuing operations

-114.20%-8.01M

155.84%17.78M

-83.53%-18.41M

40.88%-9.13M

-207.90%-11.06M

439.11%56.37M

41.53%-31.84M

37.56%-10.03M

-76.94%-15.44M

184.35%10.25M

Operating gains losses

--9K

102.90%32K

----

94.68%-1.1M

--0

103.91%500K

91.10%-486K

Depreciation and amortization

322.99%368K

-0.78%383K

27.55%125K

-11.34%86K

-7.61%85K

-12.12%87K

18.40%386K

15.29%98K

8.99%97K

22.67%92K

Other non cash items

-42.47%214K

70.26%2.43M

254.37%1.3M

7.22%386K

6.78%378K

6.59%372K

57.21%1.43M

34.07%366K

92.51%360K

--354K

Change In working capital

94.85%-3.9M

-237.82%-84.28M

-506.24%-12.34M

253.04%5.06M

94.84%-1.31M

-8,050.32%-75.69M

-247.83%-24.95M

-294.57%-2.04M

0.21%1.43M

-507.93%-25.3M

-Change in receivables

--0

-99.15%85K

--0

-96.28%85K

504.51%9.96M

381.29%4.5M

-34.08%1.12M

-74.23%2.05M

-Change in prepaid assets

198.87%1.58M

255.27%4.53M

113.53%390K

1,466.56%4.09M

39.95%-472K

-49.43%530K

-13,804.76%-2.92M

-234.22%-2.88M

74.11%-299K

27.49%-786K

-Change in payables and accrued expense

50.57%-5.48M

-7,187.41%-10.42M

91.16%-182K

-40.49%1.33M

-161.49%-479K

-904.80%-11.09M

-103.59%-143K

-615.79%-2.06M

-3.36%2.24M

-46.28%779K

-Change in other current liabilities

--0

-979.46%-13.61M

-3,773.77%-12.55M

-13.21%-360K

-13.46%-354K

-13.03%-347K

-49.23%-1.26M

-62.00%-324K

-68.25%-318K

31.13%-312K

-Change in other working capital

----

-112.09%-64.86M

--0

-6,579.92%-64.86M

-288.52%-30.58M

-0.08%-1.27M

-5.20%-1.31M

-1,508.03%-27.03M

Cash from discontinued investing activities

Operating cash flow

38.08%-11.45M

3.83%-50.47M

-59.25%-18M

75.86%-2.93M

22.53%-11.06M

-25.09%-18.49M

-7.67%-52.48M

27.10%-11.3M

28.46%-12.13M

-66.59%-14.27M

Investing cash flow

Cash flow from continuing investing activities

196.49%14.7M

-8.47%49.14M

0.76%19.54M

-98.78%122K

132.74%24.52M

-63.91%4.96M

679.02%53.69M

-3.56%19.4M

-33.85%10.03M

124.29%10.53M

Net PPE purchase and sale

--10K

80.00%-7K

--0

-109.21%-7K

--0

92.69%-35K

86.60%-41K

93.86%-7K

249.02%76K

Net investment purchase and sale

196.29%14.69M

-8.52%49.15M

0.55%19.54M

-98.78%122K

134.50%24.52M

-64.07%4.96M

628.87%53.73M

-4.80%19.44M

-34.30%10.03M

124.14%10.46M

Cash from discontinued investing activities

Investing cash flow

196.49%14.7M

-8.47%49.14M

0.76%19.54M

-98.78%122K

132.74%24.52M

-63.91%4.96M

679.02%53.69M

-3.56%19.4M

-33.85%10.03M

124.29%10.53M

Financing cash flow

Cash flow from continuing financing activities

-29,570.00%-11.87M

-208K

-100.08%-40K

Cash dividends paid

----

---11.66M

--0

----

--0

----

Net other financing activities

----

-420.00%-208K

----

98.96%-40K

--0

Cash from discontinued financing activities

Financing cash flow

----

-29,570.00%-11.87M

---208K

--0

----

-100.08%-40K

--0

Net cash flow

Beginning cash position

-78.08%3.71M

7.41%16.91M

-73.13%2.37M

-52.61%5.17M

-76.99%3.37M

7.41%16.91M

84.24%15.74M

-20.70%8.81M

-13.02%10.92M

-6.20%14.65M

Current changes in cash

123.99%3.25M

-1,232.16%-13.2M

-83.48%1.34M

-33.30%-2.81M

148.23%1.8M

-1,145.08%-13.53M

-83.80%1.17M

74.89%8.09M

-46.28%-2.11M

-21.69%-3.74M

End cash Position

106.17%6.95M

-78.08%3.71M

-73.13%2.37M

-52.61%5.17M

-76.99%3.37M

7.41%16.91M

-20.70%8.81M

-13.02%10.92M

Free cash flow

38.08%-11.45M

3.88%-50.48M

-58.76%-18M

75.86%-2.93M

22.14%-11.06M

-24.56%-18.49M

-6.69%-52.52M

28.29%-11.34M

28.94%-12.13M

-64.87%-14.21M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	38.08%-11.45M	3.83%-50.47M	-59.25%-18M	75.86%-2.93M	22.53%-11.06M	-25.09%-18.49M	-7.67%-52.48M	27.10%-11.3M	28.46%-12.13M	-66.59%-14.27M
Net income from continuing operations	-114.20%-8.01M	155.84%17.78M	-83.53%-18.41M	40.88%-9.13M	-207.90%-11.06M	439.11%56.37M	41.53%-31.84M	37.56%-10.03M	-76.94%-15.44M	184.35%10.25M
Operating gains losses	--9K	102.90%32K	----	----	----	----	94.68%-1.1M	--0	103.91%500K	91.10%-486K
Depreciation and amortization	322.99%368K	-0.78%383K	27.55%125K	-11.34%86K	-7.61%85K	-12.12%87K	18.40%386K	15.29%98K	8.99%97K	22.67%92K
Other non cash items	-42.47%214K	70.26%2.43M	254.37%1.3M	7.22%386K	6.78%378K	6.59%372K	57.21%1.43M	34.07%366K	92.51%360K	--354K
Change In working capital	94.85%-3.9M	-237.82%-84.28M	-506.24%-12.34M	253.04%5.06M	94.84%-1.31M	-8,050.32%-75.69M	-247.83%-24.95M	-294.57%-2.04M	0.21%1.43M	-507.93%-25.3M
-Change in receivables	--0	-99.15%85K	--0	--0	--0	-96.28%85K	504.51%9.96M	381.29%4.5M	-34.08%1.12M	-74.23%2.05M
-Change in prepaid assets	198.87%1.58M	255.27%4.53M	113.53%390K	1,466.56%4.09M	39.95%-472K	-49.43%530K	-13,804.76%-2.92M	-234.22%-2.88M	74.11%-299K	27.49%-786K
-Change in payables and accrued expense	50.57%-5.48M	-7,187.41%-10.42M	91.16%-182K	-40.49%1.33M	-161.49%-479K	-904.80%-11.09M	-103.59%-143K	-615.79%-2.06M	-3.36%2.24M	-46.28%779K
-Change in other current liabilities	--0	-979.46%-13.61M	-3,773.77%-12.55M	-13.21%-360K	-13.46%-354K	-13.03%-347K	-49.23%-1.26M	-62.00%-324K	-68.25%-318K	31.13%-312K
-Change in other working capital	----	-112.09%-64.86M	--0	--0	--0	-6,579.92%-64.86M	-288.52%-30.58M	-0.08%-1.27M	-5.20%-1.31M	-1,508.03%-27.03M
Cash from discontinued investing activities
Operating cash flow	38.08%-11.45M	3.83%-50.47M	-59.25%-18M	75.86%-2.93M	22.53%-11.06M	-25.09%-18.49M	-7.67%-52.48M	27.10%-11.3M	28.46%-12.13M	-66.59%-14.27M
Investing cash flow
Cash flow from continuing investing activities	196.49%14.7M	-8.47%49.14M	0.76%19.54M	-98.78%122K	132.74%24.52M	-63.91%4.96M	679.02%53.69M	-3.56%19.4M	-33.85%10.03M	124.29%10.53M
Net PPE purchase and sale	--10K	80.00%-7K	--0	--0	-109.21%-7K	--0	92.69%-35K	86.60%-41K	93.86%-7K	249.02%76K
Net investment purchase and sale	196.29%14.69M	-8.52%49.15M	0.55%19.54M	-98.78%122K	134.50%24.52M	-64.07%4.96M	628.87%53.73M	-4.80%19.44M	-34.30%10.03M	124.14%10.46M
Cash from discontinued investing activities
Investing cash flow	196.49%14.7M	-8.47%49.14M	0.76%19.54M	-98.78%122K	132.74%24.52M	-63.91%4.96M	679.02%53.69M	-3.56%19.4M	-33.85%10.03M	124.29%10.53M
Financing cash flow
Cash flow from continuing financing activities		-29,570.00%-11.87M	-208K	0			-100.08%-40K	0	0	0
Cash dividends paid	----	---11.66M	--0	--0	----	----	--0	--0	--0	----
Net other financing activities	----	-420.00%-208K	----	----	----	----	98.96%-40K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	----	-29,570.00%-11.87M	---208K	--0	----	----	-100.08%-40K	--0	--0	--0
Net cash flow
Beginning cash position	-78.08%3.71M	7.41%16.91M	-73.13%2.37M	-52.61%5.17M	-76.99%3.37M	7.41%16.91M	84.24%15.74M	-20.70%8.81M	-13.02%10.92M	-6.20%14.65M
Current changes in cash	123.99%3.25M	-1,232.16%-13.2M	-83.48%1.34M	-33.30%-2.81M	148.23%1.8M	-1,145.08%-13.53M	-83.80%1.17M	74.89%8.09M	-46.28%-2.11M	-21.69%-3.74M
End cash Position	106.17%6.95M	-78.08%3.71M	-78.08%3.71M	-73.13%2.37M	-52.61%5.17M	-76.99%3.37M	7.41%16.91M	7.41%16.91M	-20.70%8.81M	-13.02%10.92M
Free cash flow	38.08%-11.45M	3.88%-50.48M	-58.76%-18M	75.86%-2.93M	22.14%-11.06M	-24.56%-18.49M	-6.69%-52.52M	28.29%-11.34M	28.94%-12.13M	-64.87%-14.21M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data